ID

35104

Description

LIquid BIopsies in Lung Cancer (LIBIL); ODM derived from: https://clinicaltrials.gov/show/NCT02511288

Link

https://clinicaltrials.gov/show/NCT02511288

Keywords

Versions (1)
  1. 2/17/19 2/17/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 17, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

English

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 forms  
Criteria
Description

Criteria

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
Description

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0026882
UMLS CUI [2,3]
C0449438
inclusion at the time of diagnostic or at relapse
Description

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Description

Neoplasm Biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Description

Therapeutic procedure Before Liquid Biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
cohort 2 inclusion criteria
Description

Cohort Number | Inclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0237753
UMLS CUI [2]
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
Description

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C1704257
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C3266992
UMLS CUI [4]
C1511021
UMLS CUI [5]
C3273087
UMLS CUI [6]
C4329227
UMLS CUI [7]
C4331215
UMLS CUI [8]
C1711106
inclusion at the time of diagnostic or at relapse
Description

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Description

Neoplasm Biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Description

Therapeutic procedure Before Liquid Biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
Back to the top of the page

Similar models

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0026882 (UMLS CUI [2,2])
C0449438 (UMLS CUI [2,3])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Cohort Number | Inclusion criteria
Item
cohort 2 inclusion criteria
boolean
C0599755 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1704257 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3266992 (UMLS CUI [3])
C1511021 (UMLS CUI [4])
C3273087 (UMLS CUI [5])
C4329227 (UMLS CUI [6])
C4331215 (UMLS CUI [7])
C1711106 (UMLS CUI [8])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial